PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-8.32%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$629M
AUM Growth
+$629M
(-24%)
Cap. Flow
+$22.6M
Cap. Flow
% of AUM
3.6%
Top 10 Holdings %
Top 10 Hldgs %
47.7%
Holding
242
New
26
Increased
27
Reduced
24
Closed
38
Top Buys
| 1 |
Glaukos
GKOS
|
$36.2M |
| 2 |
Guardant Health
GH
|
$16.2M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$13.9M |
| 4 |
Lyra Therapeutics
LYRA
|
$11.6M |
| 5 |
Pulmonx
LUNG
|
$10.9M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$19M |
| 2 |
C4 Therapeutics
CCCC
|
$15.2M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$13.5M |
| 4 |
ICU Medical
ICUI
|
$12.8M |
| 5 |
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
|
$11.3M |
Sector Composition
| 1 | Healthcare | 90.17% |
| 2 | Industrials | 0.83% |
| 3 | Consumer Staples | 0.74% |
| 4 | Materials | 0.31% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
908 Devices
MASS
$199M
| $6.1M | 0.35% |
296,288
| – | – |
|
27
Milestone Pharmaceuticals
MIST
$151M
| $6.07M | 0.35% |
987,411
| – | – |
|
28
iRhythm Technologies
IRTC
$5.67B
| $5.4M | 0.31% |
+50,000
| New | +$5.4M |
|
|
RCM
29
DELISTED
R1 RCM Inc. Common Stock
RCM
| $5.23M | 0.3% |
249,732
+61,277
| +33% | +$1.28M |
|
30
Privia Health
PRVA
$2.84B
| $5.19M | 0.3% |
178,255
-61,945
| -26% | -$1.8M |
|
31
Agilon Health
AGL
$497M
| $5.15M | 0.3% |
236,100
+191,100
| +425% | +$4.17M |
|
32
Cytek Biosciences
CTKB
$501M
| $5.12M | 0.3% |
477,164
+52,587
| +12% | +$564K |
|
33
Avantor
AVTR
$8.74B
| $4.82M | 0.28% |
+155,000
| New | +$4.82M |
|
|
34
Vertex Pharmaceuticals
VRTX
$102B
| $4.72M | 0.27% |
16,763
-67,294
| -80% | -$19M |
|
35
AtriCure
ATRC
$1.73B
| $4.36M | 0.25% |
106,615
-230,000
| -68% | -$9.4M |
|
36
Bioventus
BVS
$471M
| $4.09M | 0.24% |
599,080
+43,170
| +8% | +$294K |
|
37
TG Therapeutics
TGTX
$5.03B
| $4.04M | 0.23% |
950,813
+622,626
| +190% | +$2.65M |
|
38
Travere Therapeutics
TVTX
$1.75B
| $4.03M | 0.23% |
166,201
+55,976
| +51% | +$1.36M |
|
39
The Beauty Health Co
SKIN
$254M
| $3.92M | 0.23% |
+305,000
| New | +$3.92M |
|
40
TELA Bio
TELA
$65.4M
| $3.9M | 0.23% |
555,623
-11,797
| -2% | -$82.7K |
|
41
BioCryst Pharmaceuticals
BCRX
$1.74B
| $3.85M | 0.22% |
+364,252
| New | +$3.85M |
|
|
KRTX
42
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.78M | 0.22% |
+29,900
| New | +$3.78M |
|
43
Codexis
CDXS
$218M
| $3.53M | 0.2% |
337,154
-128,748
| -28% | -$1.35M |
|
44
Avita Medical
RCEL
$116M
| $3.52M | 0.2% |
741,875
+67,559
| +10% | +$321K |
|
45
Jazz Pharmaceuticals
JAZZ
$7.99B
| $3.38M | 0.2% |
+21,643
| New | +$3.38M |
|
46
SOPHiA GENETICS
SOPH
$232M
| $3.11M | 0.18% |
859,930
+30,000
| +4% | +$109K |
|
|
BCYC
47
Bicycle Therapeutics
BCYC
$492M
| $3.07M | 0.18% |
+183,121
| New | +$3.07M |
|
48
Humana
HUM
$37.5B
| $3M | 0.17% |
+6,400
| New | +$3M |
|
|
ICAD
49
DELISTED
iCAD Inc
ICAD
| $2.69M | 0.16% |
672,989
| – | – |
|
50
ATAI Life Sciences
ATAI
$969M
| $2.63M | 0.15% |
721,824
-556,281
| -44% | -$2.02M |
|